LA Kelley Communications, Inc.

07/21/2025

Register for paid patient surveys... learn more here. https://www.kelleycom.com/paid-surveys/

07/18/2025

Listen to HemoLife Podcast!
http://bit.ly/44Oa5qi

07/16/2025

Download Laurie's newest book on leadership!

bit.ly/4lJcSI4

07/15/2025

This week on HemaBlog...
A Tireless Physician, Now at Rest
https://bit.ly/3TH88Xz

07/11/2025

Attend the Hem B Gene Therapy Rap Session: July 15!
https://bit.ly/409oMmj

07/09/2025

Register for InhibitCon West: October 3-5, Portland, OR

Non-Profit organization devoted to the bleeding disorder community such as Hemophilia, Von Willebrand's and the even rarer bleeding conditions. We specialize in Inhibitors, Ultra-Rare bleeding disorders, and women's health advocacy.

07/07/2025

Tainted Blood: Could It Happen Again, Now?

Kathy Seward MacKay lost her husband in 1997 because of tainted blood-clotting products. She’s worried about history repeating itself.

07/04/2025

Happy 4th of July!

07/02/2025

Read HFA's report on Cuts to Rural Healthcare

By Adam Alver, Policy Director The “Big Beautiful Bill” – HR 1 As we continue to update our community, the current budget reconciliation bill, HR 1, or the Big Beautiful Bill Act continues to make its way through Congress. Now sitting in the Senate and awaiting changes following a block by the...

07/01/2025

This week on HemaBlog...
https://bit.ly/3I5sAPi

06/27/2025

Switching from Hemlibra to Mim8 well tolerated

Directly switching from Hemlibra to Mim8 was well tolerated in people with hemophilia A, with or without inhibitors, a study found.

06/23/2025

Is Gene Therapy Slow to Catch On?

People with hemophilia are hesitant to take the FDA-approved drugs for a variety of reasons, experts say. Pharma and biotech companies have taken notice.